Literature DB >> 6099407

Second primaries in children with central nervous system tumors.

J Farwell, J T Flannery.   

Abstract

Among 670 children diagnosed with central nervous system tumors before age 20 and recorded in the Connecticut Tumor Registry, nine had a second neoplasm as well. From known age-specific and year-specific cancer incidence figures for Connecticut, the expected number of second neoplasms for the series of 670 is 0.99; therefore the relative risk is 9.1 (95% confidence limits: 4.0, 17.3). Three patients developed two central nervous system tumors, while 0.16 were expected, giving a relative risk of 19 (95% confidence limits: 3.8, 55). Six patients developed two neoplasms in childhood, versus 0.66 expected; the relative risk of this event is 9.1 (95% confidence limits: 3.3, 20). In four cases of lapse in time between the diagnosis of the first and second tumor, the first tumor had been treated with radiation. Five cancers occurred in parents or siblings of these nine patients, versus 0.91 expected; the relative risk is 5.5 (95% confidence limits: 1.2, 10.0). Three of these relatives had leukemia, while only 0.04 cases were expected (relative risk = 75). We conclude that not only is a child with CNS cancer at increased risk for other cancers, but such a child with two cancers is often part of a familial cluster with increased risk of cancer.

Entities:  

Mesh:

Year:  1984        PMID: 6099407     DOI: 10.1007/bf00178120

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  17 in total

1.  INCIDENCE OF SECOND PRIMARY TUMORS IN CHILDREN WITH CANCER AND LEUKEMIA: A SEVEN-YEAR SURVEY OF 150 CONSECUTIVE AUTOPSIED CASES.

Authors:  W REGELSON; I D BROSS; J HANANIAN; G NIGOGOSYAN
Journal:  Cancer       Date:  1965-01       Impact factor: 6.860

2.  Multiple diverse primary brain tumors.

Authors:  M J MADONICK; J H SHAPIRO; R M TORACK
Journal:  Neurology       Date:  1961-05       Impact factor: 9.910

3.  Glioblastoma multiforme in a patient with acute lymphoblastic leukemia who received a marrow transplant.

Authors:  J Sanders; G E Sale; R Ramberg; R Clift; C D Buckner; E D Thomas
Journal:  Transplant Proc       Date:  1982-12       Impact factor: 1.066

4.  Medulloblastoma, thyroid carcinoma, and recurrent brain tumor in the same patient.

Authors:  J G Rosenstock
Journal:  Med Pediatr Oncol       Date:  1982

5.  Adrenocortical neoplasms with hemihypertrophy, brain tumors, and other disorders.

Authors:  J F Fraumeni; R W Miller
Journal:  J Pediatr       Date:  1967-01       Impact factor: 4.406

6.  Second neoplasms following megavoltage radiation in a pediatric population.

Authors:  R E Haselow; M Nesbit; L P Dehner; F M Khan; R McHugh; S H Levitt
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

7.  Childhood acute lymphocytic leukemia with a second primary neoplasm.

Authors:  T R Walters
Journal:  Am J Pediatr Hematol Oncol       Date:  1979

8.  Cancer in relatives of children with central-nervous-system neoplasms.

Authors:  J Farwell; J T Flannery
Journal:  N Engl J Med       Date:  1984-09-20       Impact factor: 91.245

9.  Patterns of second malignant neoplasms in children.

Authors:  A T Meadows; G J D'Angio; V Miké; A Banfi; C Harris; R D Jenkin; A Schwartz
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

10.  Multiple disparate cranial neoplasms.

Authors:  A K Frazer; G C Victoratos
Journal:  Cancer       Date:  1979-12       Impact factor: 6.860

View more
  9 in total

Review 1.  Post-radiation glioma in a child. Case report and review of the literature.

Authors:  L Palma; R Vagnozzi; L Annino; P Ciapetta; A Maleci; G Cantore
Journal:  Childs Nerv Syst       Date:  1988-10       Impact factor: 1.475

2.  Potential risk factors for brain tumors in children. An analysis of 200 cases.

Authors:  R Giuffrè; G Liccardo; F S Pastore; A Spallone; R Vagnozzi
Journal:  Childs Nerv Syst       Date:  1990-01       Impact factor: 1.475

Review 3.  Environmental risk factors for primary malignant brain tumors: a review.

Authors:  M Wrensch; M L Bondy; J Wiencke; M Yost
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

4.  Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom.

Authors:  C R Buchanan; M A Preece; R D Milner
Journal:  BMJ       Date:  1991-04-06

5.  Supratentorial astrocytic tumours of childhood: a clinicopathologic study of 41 cases.

Authors:  S Nishio; I Takeshita; K Fujii; M Fukui
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

Review 6.  Biological aspects of brain tumors in infancy and childhood.

Authors:  R Giuffrè
Journal:  Childs Nerv Syst       Date:  1989-04       Impact factor: 1.475

7.  Risk of subsequent cancer following a primary CNS tumor.

Authors:  Kyle Strodtbeck; Andrew Sloan; Lisa Rogers; Paul Graham Fisher; Duncan Stearns; Laura Campbell; Jill Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2013-02-08       Impact factor: 4.130

8.  Incidence of second primary tumours among childhood cancer survivors.

Authors:  M M Hawkins; G J Draper; J E Kingston
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

9.  Patterns of multiple primary tumours in patients treated for cancer during childhood.

Authors:  J E Kingston; M M Hawkins; G J Draper; H B Marsden; L M Kinnier Wilson
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.